MENS · Jyong Biotech Ltd.
Market Cap
$174.86M
Shares
76.03M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Net Income
-$4.67M
-54.7%
FY2025
Diluted EPS
-$0.06
-50%
FY2025
Operating Cash Flow
-$3.04M
+16.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| $813K | $927K | $1.07M | |
| $45K | $44K | $47K | |
| $1.75M | $1.09M | $1.68M | |
| $100K | $120K | $127K | |
| $2.61M | $2.06M | $2.8M | |
| -$2.61M | -$2.06M | -$2.8M | |
| $2.54M | $1.04M | $757K | |
| $610K | $7000 | $56K | |
| -$2.06M | -$963K | -$1.6M | |
| -$4.67M | -$3.02M | -$4.4M | |
| -$4.67M | -$3.02M | -$4.4M | |
| USD/shares | -$0.06 | -$0.04 | -$0.06 |
| USD/shares | -$0.06 | -$0.04 | -$0.06 |
| shares | 73.01M | 71.57M | 71.57M |
| shares | 73.01M | 71.57M | 71.57M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.58×
EV/EBIT
—
Peer median 11.68×
P/E (TTM)
—
Peer median 8.71×
Peer medians compare against the 294 similar-size Biotechnology companies (of 515 listed).